Last A$0.03 AUD
Change Today 0.00 / 0.00%
Volume 119.2K
GTG On Other Exchanges
As of 9:20 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark J. Ostrowski

Senior Vice President Sales & Marketing - Phenogen Sciences Inc, Genetic Technologies Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Mark J. Ostrowski has been a Senior Vice President of Sales and Marketing at Genetic Technologies Limited since September 7, 2012. Mr. Ostrowski is responsible for managing the U.S. sales. He served as the Chief Executive Officer and President of Sera Prognostics Inc. since April 19, 2011. He served as Senior Vice President of Sales at Perlegen Sciences Inc., since January 2009. Mr. Ostrowski served as Vice President of Sales and Marketing at GenVault Corporation ...

Read Full Background

Corporate Headquarters*

60-66 Hanover Street
Fitzroy, Victoria 3065


Phone: 61 3 8412 7000
Fax: 61 3 8412 7040

Board Members Memberships*

There is no Board Members Memberships data available.


Yale University
Yale University

Other Affiliations*

Annual Compensation*

Total Annual CompensationA$221,953

Stock Options*

All Other CompensationA$10,778
Unexercisable Options2,400,000
Total Number of Options2,400,000

Total Compensation*

Total Annual Cash CompensationA$232,731
Total Short Term CompensationA$221,953
Other Long Term CompensationA$10,778
Total Calculated CompensationA$296,280
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTG:AU A$0.03 AUD 0.00


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
William P. Sullivan Chief Executive Officer, President, Executive Director and Member of Executive Committee
Agilent Technologies Inc.
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at